{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:00Z","timestamp":1793640660472,"version":"4.5.1"},"reference-count":25,"publisher":null,"issue":"10","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim.<\/jats:italic>\n                    Assessment of the inflammatory component of acute coronary syndrome (ACS) and the degree of activation of the coagulation cascade may provide prognostic information. The systemic coagulation-inflammation index (SCI) assesses both inflammation and the coagulation system, and it has also been found to be associated with clinical outcomes. We investigated the relationship between SCI and in-hospital clinical events (acute kidney injury, cardiogenic shock, life-threatening arrhythmia, bleeding) and mortality.\n                    <jats:italic>Material and methods.<\/jats:italic>\n                    The study included 396 patients aged \u226518 yrs who were hospitalized with a diagnosis of ACS. The SCI was calculated using the formula: platelet count (103 \/ \u00b5l) X fibrinogen (g \/ l) \/ white blood cell (WBC) count (103 \/ \u00b5l). Patients were divided into two groups according to whether their SCI score was &gt;100 or &lt;100, and the relationship between clinical and laboratory characteristics was analyzed accordingly.\n                    <jats:italic>Results.<\/jats:italic>\n                    The mean age of the patients was 61.4\u00b112.2 years and 78.3 % (n=310) were male. The type of ACS was NSTEMI in 56.1 % (n=222). The responsible vessel was the left anterior descending artery (LAD) in 42.4 % of the patients (n=168). The mean SCI score was 97.5\u00b147.1. WBC, neutrophil, and lymphocyte counts were higher in the SCI &lt;100 group, whereas fibrinogen, C-reactive protein, and platelet count were higher in the SCI &gt;100 group. Bleeding from any cause as an in-hospital complication was significantly higher in patients with SCI &gt;100 (p&lt;0.05). Other in-hospital events were not significantly associated with SCI (p&gt;0.05).\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    Bleeding in ACS patients was significantly more common in the group with SCI &gt;100. Thus, SCI may be a useful parameter for predicting in-hospital bleeding complications in ACS. On the other hand, SCI was not associated with mortality and other in-hospital clinical events.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2023.10.n2586","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T11:02:23Z","timestamp":1700132543000},"page":"72-77","source":"Crossref","is-referenced-by-count":6,"title":["Systemic Coagulation Inflammation Index Associated With Bleeding in Acute Coronary Syndrome"],"prefix":"10.68900","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0758-649X","authenticated-orcid":true,"given":"\u0130.","family":"Zengin","sequence":"first","affiliation":[{"name":"Bursa City Hospital, Department of Cardiology, Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5789-5691","authenticated-orcid":true,"given":"K.","family":"Severg\u00fcn","sequence":"additional","affiliation":[{"name":"Bursa Y\u00fcksek Ihtisas Training and Research Hospital, Department of Cardiology, Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Centuri\u00f3n OA. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Cardiovascular Revascularization Medicine. 2016;17(2):119\u201328. DOI: 10.1016\/j.carrev.2016.01.005","DOI":"10.1016\/j.carrev.2016.01.005"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sibbing D, Angiolillo DJ, Huber K. Antithrombotic therapy for acute coronary syndrome: Past, present and future. Thrombosis and Haemostasis. 2017;117(7):1240\u20138. DOI: 10.1160\/TH16-12-0963","DOI":"10.1160\/TH16-12-0963"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Denegri A, Boriani G. High Sensitivity C-reactive Protein (hsCRP) and its Implications in Cardiovascular Outcomes. Current Pharmaceutical Design. 2021;27(2):263\u201375. DOI: 10.2174\/1381612826666200717090334","DOI":"10.2174\/1381612826666200717090334"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Review of Cardiovascular Therapy. 2016;14(5):573\u20137. DOI: 10.1586\/14779072.2016.1154788","DOI":"10.1586\/14779072.2016.1154788"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kounis NG, Koniari I, Plotas P, Soufras GD, Tsigkas G, Davlouros P et al. Inflammation, Thrombosis, and Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes. Angiology. 2021;72(1):6\u20138. DOI: 10.1177\/0003319720946213","DOI":"10.1177\/0003319720946213"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. Journal of Clinical Medicine. 2023;12(3):1128. DOI: 10.3390\/jcm12031128","DOI":"10.3390\/jcm12031128"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mahmud E, Ramsis M, Behnamfar O, Enright K, Huynh A, Kaushal K et al. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention. The American Journal of Cardiology. 2016;117(10):1575\u201381. DOI: 10.1016\/j.amjcard.2016.02.032","DOI":"10.1016\/j.amjcard.2016.02.032"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Liu H, Qian S, Shao Y, Li H, Zhang H. Prognostic Impact of Systemic Coagulation-Inflammation Index in Acute Type A Aortic Dissection Surgery. JACC: Asia. 2022;2(6):763\u201376. DOI: 10.1016\/j.jacasi.2022.06.007","DOI":"10.1016\/j.jacasi.2022.06.007"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Civeira F, Arca M, Cenarro A, Hegele RA. A mechanism-based operational definition and classification of hypercholesterolemia. Journal of Clinical Lipidology. 2022;16(6):813\u201321. DOI: 10.1016\/j.jacl.2022.09.006","DOI":"10.1016\/j.jacl.2022.09.006"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. The Lancet. 2017;389(10075):1238\u201352. DOI: 10.1016\/S0140-6736(16)32064-5","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Caiazzo G, Musci RL, Frediani L, Umi\u0144ska J, Wanha W, Filipiak KJ et al. State of the Art: No-Reflow Phenomenon. Cardiology Clinics. 2020;38(4):563\u201373. DOI: 10.1016\/j.ccl.2020.07.001","DOI":"10.1016\/j.ccl.2020.07.001"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney International. 2021;100(3):516\u201326. DOI: 10.1016\/j.kint.2021.06.028","DOI":"10.1016\/j.kint.2021.06.028"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Thiele H, De Waha-Thiele S, Freund A, Zeymer U, Desch S, Fitzgerald S. Management of cardiogenic shock. EuroIntervention. 2021;17(6):451\u2013 65. DOI: 10.4244\/EIJ-D-20-01296","DOI":"10.4244\/EIJ-D-20-01296"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Alkhalfan F, Nafee T, Yee MK, Chi G, Kalayci A, Plotnikov A et al. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial). The American Journal of Cardiology. 2020;125(5):661\u20139. DOI: 10.1016\/j.amjcard.2019.12.007","DOI":"10.1016\/j.amjcard.2019.12.007"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bod\u00ed V, Llacer A, Sanchis J, Nunez J, Nunez E. Prognostic Value of Leukocytosis in Acute Coronary Syndromes: The Cinderella of the Inflammatory Markers. Current Medicinal Chemistry. 2006;13(18):2113\u20138. DOI: 10.2174\/092986706777935221","DOI":"10.2174\/092986706777935221"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Eber B, Schumacher M. Fibrinogen: Its Role in the Hemostatic Regulation in Atherosclerosis. Seminars in Thrombosis and Hemostasis. 1993;19(02):104\u20137. DOI: 10.1055\/s-2007-994012","DOI":"10.1055\/s-2007-994012"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Gil M, Zar\u0119bi\u0144ski M, Adamus J. Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina. International Journal of Cardiology. 2002;83(1):43\u20136. DOI: 10.1016\/S0167-5273(02)00008-6","DOI":"10.1016\/S0167-5273(02)00008-6"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease. Circulation. 1997;96(12):4204\u201310. DOI: 10.1161\/01.CIR.96.12.4204","DOI":"10.1161\/01.CIR.96.12.4204"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Verheggen P, de Maat MP, Cats VM, Haverkate F, Zwinderman AH, Kluft C et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. European Heart Journal. 1999;20(8):567\u201374. DOI: 10.1053\/euhj.1998.1312","DOI":"10.1053\/euhj.1998.1312"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Koike K et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arteriosclerosis and Thrombosis. 1993;13(6):783\u201390. DOI: 10.1161\/01.ATV.13.6.783","DOI":"10.1161\/01.ATV.13.6.783"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Campbell CL, Steinhubl SR, Hooper WC, Jozic J, Smyth SS, Bernstein D et al. Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy. Journal of Thrombosis and Thrombolysis. 2011;31(2):139\u201345. DOI: 10.1007\/s11239-010-0513-1","DOI":"10.1007\/s11239-010-0513-1"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH et al. Association of a History of Systemic Hypertension With Mortality, Thrombotic, and Bleeding Complications Following Non\u2010ST\u2010Segment Elevation Acute Coronary Syndrome. The Journal of Clinical Hypertension. 2006;8(5):315\u201322. DOI: 10.1111\/j.1524-6175.2006.05384.x","DOI":"10.1111\/j.1524-6175.2006.05384.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Manoukian SV. Predictors and Impact of Bleeding Complications in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology. 2009;104(5 Suppl):9C-15C. DOI: 10.1016\/j.amjcard.2009.06.020","DOI":"10.1016\/j.amjcard.2009.06.020"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, AllenLaPointe NM et al. Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non\u2013ST-Segment Elevation Acute Coronary Syndromes. JAMA. 2005;294(24):3108\u201316. DOI: 10.1001\/jama.294.24.3108","DOI":"10.1001\/jama.294.24.3108"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hamilos M, Petousis S, Xanthopoulou I, Goudevenos J, Kanakakis J, Sitafidis G et al. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy. Coronary Artery Disease. 2018;29(1):53\u20139. DOI: 10.1097\/MCA.0000000000000547","DOI":"10.1097\/MCA.0000000000000547"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/2586\/1459","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:32Z","timestamp":1793639792000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/2586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,11,10]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2023.10.n2586","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}